期刊文献+

早期类风湿关节炎寒热证候分类与细胞因子及有关临床指标的相关性研究 被引量:13

Correlation Between Heat or Cold Syndrome and Cytokine, and Laboratory Index in Women with Early Rheumatoid Arthritis
下载PDF
导出
摘要 目的:探索早期类风湿关节炎(RA)寒、热证候分类的客观基础,研究中医四诊信息与RA细胞因子、临床炎性指标、临床免疫学指标的相关性。方法:随机选取符合纳入标准的早期RA女性患者70例,按RA证候问卷表采集患者各项证候信息,参照相应标准进行寒、热证候判断,活动性判断。同时,取患者晨起空腹血样,检测细胞因子、临床炎性指标和临床免疫学检查指标。采用两因素方差分析为主的显著性检验方法,在控制RA活动性的基础上,分析各客观指标在寒、热证候之间的差异。结果:除C反应蛋白(CRP)外,早期女性RA寒热证候患者细胞因子(IL-8、TNF-α、IL-10),临床炎性检查指标(ESR),及各免疫学指标(IgA、IgM、IgG、RF、C3)的值未见显著性差异。结论:早期RA患者寒热证候之间CRP有显著性差异,寒证的CRP低于热证,提示CRP可以作为RA寒热证候分类的微观指标之一。 Objective: To evaluate the diagnositic value of the cytokines (TNF- α, IL-10, IL-8), clinical inflammatory indexes (ESR, CRP), and clinical immune indexes (IgA, IgM, IgG, RF, C3) on heat or cold syndrome in female patients with rheumatoid arthrifis(RA) of early stage. Methods: 70 female RA patients were divided into heat and cold syndrome type. The blood samples were collected and detected for the following indexes such as cytokines, clinical inflammatory indexes, clinical immune indexes. The results were analyzed by two-way classification ANOYA. Results" Except CLIP, the expression of cytokine (TNF-α, IL-, IL-8), clinical inflammatory indexes (ESR), immune indexes (IgA, IgG, IgM, RF, C3)of subjects with heat and cold syndrome had no significant difference. Conclusion: Female RA patients with heat syndrome have higher expression of CRP than those with cold syndrome, which indicates that CRP has potential diagnositic value to heat and cold syndrome in RA.
出处 《上海中医药大学学报》 CAS 2006年第1期21-24,共4页 Academic Journal of Shanghai University of Traditional Chinese Medicine
基金 国家自然科学基金重大研究计划重点资助项目(90209002)
关键词 类风湿关节炎 证候 细胞因子 炎性指标 免疫学 Rheumatoid arthritis syndrome cytokine inflammatory indexes immunology
  • 相关文献

参考文献11

二级参考文献17

  • 1陈鸿耀,刘宝铨,吴敏霞,朱晴晖,李晓迅,章谷生.梗阻性黄疸患者细胞免疫功能的改变[J].上海免疫学杂志,1994,14(6):339-342. 被引量:7
  • 2陈鸿耀,刘宝铨,杨戟,丁颐艺,吴敏霞,朱晴晖,李晓迅,何亮家,章谷生.外科感染病例TNF动态变化的临床评价[J].中国普通外科杂志,1994,3(6):331-332. 被引量:2
  • 3蒋明 朱立平 等.风湿病学(第3版)[M].北京:科学出版社,1998.538.
  • 4郑筱萸.中药新药治疗类风湿性关节炎的临床研究指导原则[S]..中药新药临床研究指导原则[C].北京:中国医药科技出版杜,2002.116.
  • 5Gays S, Renate EG, William JK, et al. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis;two cellular mechanisms explain joint destruction[J], Ann Rheum Dis, 1993,52 suppl:39-42.
  • 6中华人民共和国卫生部.中药新药临床研究指导原则.第1辑[M].,1993.118-121.
  • 7吴少祯主编.常见疾病的诊断与疗效判定(标准).北京:中国中医药出版社,1993.352.
  • 82,Gay S,Gay R,Koopman WJ,et al.The mechanism of tissue injure for the patients withrheumatoid arthritis,Ann Rheum Dis,1993,52(suppl):39
  • 93,Rubin LA,Nelson DL.The soluble interlenkin 2 receptor:Biology fun-ction and clinicalapplication.Ann Intern Med,1990,113:619
  • 104,Rajan M,Anne C,John W,et al.The significance of determination of tumor necrosis factorin patients with chornic infection,Ann Rheum Dis,1993,52:232

共引文献52

同被引文献178

引证文献13

二级引证文献142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部